PharmacovigilanceOfficial

Breckenridge recalls one lot of propranolol ER 60 mg capsules over possible metal contamination

🇺🇸 FDA MedWatch · Fri 20 Nov 2026

The consumer-level US recall covers a single lot made by Adare Pharma Solutions, after a related lot with suspected metal contamination was held back from the market.

Breckenridge Pharmaceutical is voluntarily recalling one lot of Propranolol Hydrochloride Extended-Release Capsules USP 60 mg to consumer level across the US, citing potential metal contamination. The company announced the recall on 16 November 2026, and FDA published it on 20 November. The capsules were manufactured by Adare Pharma Solutions.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA MedWatch ↗

Article written by VigiEye from the official source (FDA MedWatch). AI-assisted; check the source before acting.